Mammographic screening in BRCA1 mutation carriers postponed until age 40: Evaluation of benefits, costs and radiation risks using models

European Journal of Cancer (2016) - Comment
pubmed: 27318001 doi: 10.1016/j.ejca.2016.05.012 issn: 1879-0852 issn: 0959-8049

Inge-Marie Obdeijn, Eveline A.M. Heijnsdijk, M.G. Myriam Hunink, Madeleine M.A. Tilanus-Linthorst, Harry J. De Koning